 |
UDAIPUR, India, April 29, 2025 /PRNewswire/ -- India based Hindustan Zinc Limited, a Vedanta Group company and the world's largest integrated zinc producer, announced its financial results for the year ended 31st March 2025 on 25th April 2025. The company recorded its ever-highest annual production of mined and refined metal of 1,095 KT and 1,052 KT respectively. The company delivered robust financials with FY25 revenue soaring 18% YoY to US$ 4,031 million. Hindustan Zinc also registered a robust FY25 EBITDA of US$ 2,066 million, up 28% YoY with an industry leading margin of c.51%, up 400 bps YoY. The company delivered robust full year profit after tax of US$ 1,224 million, up 33% YoY driven by 4-year lowest zinc cost of production at US$ 1,052/MT. Hindustan Zinc recorded the highest-ever Return on Capital Employed^ of 58%, best in the industry. In FY25, Hindustan Zinc generated strong Free Cash Flow from operations (pre-capex) of US$ 1,630 million. In FY25, Hindustan Zinc delivered total shareholder returns of c.68% and ranks among the Top 3 companies in India's Nifty Metal Index with a market capitalization of US$ 23 billion. The company has recently been included in the Futures & Options (F&O) segment on the National Stock Exchange (NSE). The company has consistently maintained an investment grade rating of AAA from CRISIL. Hindustan Zinc holds the second highest zinc reserves & resources globally with 25+ years of mine life and also surpassed 13.1 Mt of metal reserves (net of 1.2 Mt production)for the first time^.
Arun Misra, Chief Executive Officer, said: "Hindustan Zinc's record production is a result of improved operational efficiencies, AI integration, and a strong focus on digitalization and automation. As the world's largest integrated zinc producer, we are committed to meeting rising demand while maintaining our position as one of the lowest-cost and most sustainable producers globally. "
USD-INR rate is 84.55
^since underground transition
About Hindustan Zinc Limited
Hindustan Zinc Limited, a Vedanta Group company, is the world's largest integrated zinc producer and supplies to more than 40 countries globally. The company has been recognized as the world's most sustainable metals & mining company by the S&P Global CSA 2024.
Disclaimer
This release contains forward-looking statements that may differ from actual results. We undertake no obligation to update them.
UDAIPUR, India, April 29, 2025 /PRNewswire/ -- India based Hindustan Zinc Limited, a Vedanta Group company and the world's largest integrated zinc producer, announced its financial results for the year ended 31st March 2025 on 25th April 2025. The company recorded its ever-highest annual production of mined and refined metal of 1,095 KT and 1,052 KT respectively. The company delivered robust financials with FY25 revenue soaring 18% YoY to US$ 4,031 million. Hindustan Zinc also registered a robust FY25 EBITDA of US$ 2,066 million, up 28% YoY with an industry leading margin of c.51%, up 400 bps YoY. The company delivered robust full year profit after tax of US$ 1,224 million, up 33% YoY driven by 4-year lowest zinc cost of production at US$ 1,052/MT. Hindustan Zinc recorded the highest-ever Return on Capital Employed^ of 58%, best in the industry. In FY25, Hindustan Zinc generated strong Free Cash Flow from operations (pre-capex) of US$ 1,630 million. In FY25, Hindustan Zinc delivered total shareholder returns of c.68% and ranks among the Top 3 companies in India's Nifty Metal Index with a market capitalization of US$ 23 billion. The company has recently been included in the Futures & Options (F&O) segment on the National Stock Exchange (NSE). The company has consistently maintained an investment grade rating of AAA from CRISIL. Hindustan Zinc holds the second highest zinc reserves & resources globally with 25+ years of mine life and also surpassed 13.1 Mt of metal reserves (net of 1.2 Mt production)for the first time^.
Arun Misra, Chief Executive Officer, said: "Hindustan Zinc's record production is a result of improved operational efficiencies, AI integration, and a strong focus on digitalization and automation. As the world's largest integrated zinc producer, we are committed to meeting rising demand while maintaining our position as one of the lowest-cost and most sustainable producers globally. "
USD-INR rate is 84.55
^since underground transition
About Hindustan Zinc Limited
Hindustan Zinc Limited, a Vedanta Group company, is the world's largest integrated zinc producer and supplies to more than 40 countries globally. The company has been recognized as the world's most sustainable metals & mining company by the S&P Global CSA 2024.
Disclaimer
This release contains forward-looking statements that may differ from actual results. We undertake no obligation to update them.
** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **
Hindustan Zinc beats estimates, FY25 Profit Soars 33% to US$ 1,224 million with record production
T. Rowe Price Investment Management, Inc. and Braidwell LP participate as new investors
Stephen Williams, MD, Ph.D. joins as Chief Scientific Officer
Rebecca Chambers and Frank Witney, Ph.D. appointed to Board of Directors
FREMONT, Calif., Jan. 12, 2026 /PRNewswire/ -- Alamar Biosciences, Inc. ("Alamar"), a leader in precision proteomics dedicated to advancing the early detection of disease, announced the close of an oversubscribed convertible notes financing, bringing in more than $50 million of new capital. Accounts advised by T. Rowe Price Investment Management, Inc. and Braidwell LP joined the financing as new investors. Existing investors, including Illumina Ventures and Sands Capital, also participated. The financing will support the continued commercial advancement of Alamar's precision proteomics platform.
"We deeply appreciate the continued support from our existing investors and are excited to welcome our new partners," said Dr. Yuling Luo, founder, chairman, and chief executive officer of Alamar. "Their confidence in our vision and strategy underscores the transformative potential of our work. This investment will enable us to accelerate innovation and continue to expand the reach of our platform, unlocking the full value of precision medicine and early disease detection."
Leadership and Board Expansion
Alamar also announced key additions to its executive leadership team and board of directors to support the company's continued growth and commitment to operational excellence.
To further strengthen its scientific leadership, Alamar welcomes Dr. Stephen Williams as Chief Scientific Officer. Steve brings more than three decades of experience in precision medicine and biomarker innovation. He most recently served as Chief Medical Officer at Standard BioTools and SomaLogic, and previously spent 18 years at Pfizer in senior leadership roles. A recognized leader in the scientific community, he has served on the NIH National Advisory Council for Biomedical Imaging and Bioengineering, helped launch the Alzheimer's Disease Neuroimaging Initiative, and co-founded the FDA-FNIH-PhRMA Biomarker Consortium.
Alamar has also appointed Rebecca Chambers and Dr. Frank Witney as directors to its board. Rebecca, Chief Financial Officer at Veracyte, brings deep financial and healthcare leadership experience from her current role as well as previous positions at Outset Medical, Illumina, Myriad Genetics and Life Technologies. Frank, an operating partner at Ampersand Capital Partners, adds over three decades of life sciences leadership experience, including serving as President and CEO of Affymetrix and Dionex Corporation, and currently sits on the boards of Revvity, Cerus Corporation, Standard BioTools, and several private companies.
"I am thrilled to welcome Steve to our leadership team, and Rebecca and Frank to our board of directors," said Dr. Yuling Luo. "Their deep expertise and diverse perspectives will be invaluable as we accelerate our mission to unleash the power of our Precision Proteomics platform, to enable broad impacts across health and disease. This is an exciting moment for Alamar, and we look forward to the impact their leadership will have on driving innovation and growth."
About Alamar Biosciences, Inc.
Alamar Biosciences is a privately held life sciences company dedicated to powering precision proteomics to enable the earliest detection of disease. Leveraging its proprietary NULISA™ technology and the ARGO™ HT System, Alamar's platform is designed to deliver ultra-high sensitivity and addresses key limitations of existing technologies to deliver precision proteomics. For more information, please visit alamarbio.com.
** The press release content is from PR Newswire. Bastille Post is not involved in its creation. **
Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team
Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team
Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team
Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team
